mMed Patent Portfolio

The technology protected by the five granted U.S. patents in the mMed patent portfolio could significantly advance medication management, including the delivery of essential medical information not communicated today. These mHealth patents were issued by the USPTO between July 2010 and July 2012. The Israel and Australia patent offices have granted patents extending protection of some allowed claims from the United States to those two countries. A patent is pending in the E.U.

mMed Patent Portfolio

What is mHealth?

mHealth is the use of mobile and wireless devices to improve health outcomes, healthcare services and health research.

The definition was developed by a National Institutes of Health (NIH) Consensus group; the NIH is an agency of the U.S. Department of Health and Human Services.

Licensing Opportunities

New Directions Technology Consulting is the exclusive market developer for the mMed patent portfolio, which relates to technologies that take a medication management program into "the wild," wherever mobile patients take their meds. New Directions partners to develop mobile medication management systems based on the patents.